US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz ...
What Are Actinic Keratoses? Actinic keratoses (AKs) are a common skin condition characterized by rough, red, scaly patches, crusts, or sores on the top layer of skin (see Figures 1 & 2).
It's a variant of actinic keratosis (AK), another precancerous skin condition that can happen on other parts of the body. The ...
This key catalyst highlights Biofrontera's commitment to expanding treatment options for actinic keratoses, a condition affecting millions worldwide. Currently, BFRI is trading at $1.05 up by 3.96 ...
Biofrontera Inc. has completed enrollment for its Phase 3 clinical trial of Ameluz® photodynamic therapy (PDT), aiming to treat mild to moderate actinic keratoses (AKs) on the neck, trunk ...
Cutaneous squamous cell carcinoma (SCC) and inflammation of actinic keratosis (AK) were reported in 2 patients treated with sorafenib (Lacouture et al), but the scope of this observation has not ...